Merck, Glenmark Cut Deal With End Payors Before Zetia Trial

By Cara Salvatore · April 20, 2023, 8:44 PM EDT

Drug companies Merck and Glenmark Pharmaceuticals have reached their second settlement during jury selection for a trial on claims of an anticompetitive pay-for-delay settlement in 2010 over the cholesterol drug Zetia,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In Re: Zetia (Ezetimibe) Antitrust Litigation

Case Number

2:18-md-02836

Court

Virginia Eastern

Nature of Suit

Anti-Trust

Date Filed

June 15, 2018